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ABSTRACT. This study aimed to develop and validate real-time PCR 
for the diagnosis of Mycobacterium bovis isolates. Two hundred and 
seventy-four M. bovis isolates and 156 M. tuberculosis isolates were 
tested. Both qPCRs amplified all of the 274 M. bovis samples, but none 
of the 156 M. tuberculosis samples. The qPCR for PE-PGRS 20 had 91% 
efficiency and a detection limit of 0.32 ng (sensitivity and specificity for 
qPCR “Mbovis.100” were 99.64 and 100%, respectively). The qPCR 
for RD4 had 100% efficiency, and a detection limit of 4 pg (diagnostic 
sensitivity and specificity were 100 and 100%. The qPCR tests were 
performed using 4 extraction sets, 3 qPCR kits, and with a range of 
equipment; yet, all combinations produced similar results in a diagnostic 
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test, demonstrating the robustness of this method. The techniques proved 
to be efficient, robust, sensitive, and specific for the diagnosis of M. bovis.
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INTRODUCTION
Bovine tuberculosis (TB) is a chronic granulomatous disease. The causative agent is 
Mycobacterium bovis, which is a member of the Mycobacterium tuberculosis complex (MTC) 
that infects several species of domestic animals and wildlife, in addition to human. Economic 
losses determined by this disease are manifested by a 10 to 20% reduction in milk production, 
in addition to weight gain, infertility, death, and condemnation of animal carcasses (Ministério 
da Agricultura Pecuária e Abastecimento, 2006). Yet, evidence supporting that M. bovis is a 
meat-borne hazard is lacking, worldwide. However, bovine TB has contributed to the limita-
tion, and even prohibition, of Brazilian beef trade.
The tuberculin skin test is used for the traditional diagnosis of bovine TB, with bacterial 
isolation providing a confirmative and gold standard test [Ministério da Agricultura Pecuária e 
Abastecimento, 2006; OIE (World Organization for Animal Health), 2010]. A major limitation 
of M. bovis isolation is the delay in obtaining the results, because of the slow growth of the bacil-
lus, requiring at least 4 weeks. After detecting the growth of the colonies, it is still necessary to 
confirm the species by phenotypic tests. Because large numbers of bacteria are required to per-
form all of the tests, it is often necessary to start a new culture of M. bovis, consequently delaying 
the final result by a further 3 weeks (Ministério da Agricultura Pecuária e Abastecimento, 2006).
Therefore, establishments suspected of bovine TB need diagnostic methods that are 
faster than bacteriological diagnosis, to clarify the actual status of the disease in their livestock 
herds. In addition, current phenotypic methods for TB bovine diagnosis are slow, and are not 
considered 100% reliable, because of the presence of intermediate strains that respond different 
to biochemical tests like niacin, the thiophene-2-carboxylic acid hydrazide variant M. tuber-
culosis, and the pyrazinamide variant M. bovis [Konno et al., 1967; OIE (World Organization 
for Animal Health), 2010]. The molecular approach might represent an alternative technique 
to replace or complement existing bacteriological methods of confirmation. The molecular ap-
proach is based on the detection of specific sequences of the M. bovis genome.
M. tuberculosis is the major cause of human TB; however, M. bovis may cause similar 
symptoms, and requires different treatment because of its natural resistance to pyrazinamide 
(Konno et al., 1967). The main mode of transmission of the agent from animals to man is by 
eating animal products, such as milk, or products contaminated with the bacillus (Silva et al., 
2013). The situation is highly concerning in Brazil, where 41% of milk is produced illegally and 
consumed in the form of cheeses, yogurts, and milk, without proper thermal processing. This risk 
is further heightened by 5% of the herds and 0.85% of the cattle in Brazil being demonstrated 
to be tuberculin reactors by the Brazilian Ministry of Agriculture. Even the attenuated strain 
of M. bovis BCG, which is commonly used in human vaccination, may cause clinical signs in 
humans, as already proven in patients with cellular immunodeficiency (Talbot et al., 1997) and 
neonates (Jou et al., 2009), and may generate complications exclusively related to BCG.
The similarity between the M. bovis and M. tuberculosis genomes presents a major 
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problem in the use of molecular methods for the differentiation of these microorganisms. The 
genetic similarity between the two bacilli reaches 99.95%, with the deletions being the main 
differences between the two (Fleischmann et al., 2002; Garnier et al., 2003). The accurate 
differentiation of MTC members is clinically important because of the intrinsic variations 
of these members to anti-tuberculosis drugs (Somoskovi et al., 2009). As such, the ability to 
differentiate among MTC members might potentially allow the surveillance of zoonotic expo-
sure, in addition to providing accurate epidemiological information (Reddington et al., 2011).
Molecular biological methods have wide application in the laboratory diagnosis of 
animal diseases. PCR has several advantages compared to traditional methods of diagnosis, 
because it is highly sensitive, specific, and rapid. To produce a positive diagnosis, only a small 
number of cells are required; they do not have to be viable, and even poorly preserved samples 
may be used (Martinez et al., 2001). qPCR has higher precision, reproducibility, better quality 
control in the process, a lower risk of contamination, and eliminates the need for using elec-
trophoresis (Wittwer et al., 2001). Furthermore, this technique reduces the analysis time to just 
1-2 days, which is important to improve the currently time-consuming lengthy diagnosis of TB.
The current study aimed to develop 2 qPCR techniques using DNA intercalating 
agents for the molecular identification of M. bovis isolates.
MATERIAL AND METHODS
Ethics statement
We received M. tuberculosis samples from an already-existing collection at Empresa 
Brasileira de Pesquisa Agropecuária (Embrapa) Gado de Leite, Brazil. These samples were 
collected during a previous project conducted by Dr. Marcio Roberto Silva. All samples from 
humans were made anonymous. All M. bovis samples were isolated from lesions suggestive of 
tuberculosis that were collected from bovine in slaughterhouses around Brazil.
Primer design and qPCR
The primers designed to detect polymorphisms were based on the complete genome 
of M. bovis (Garnier et al., 2003). First, the sequences were subjected to BLAST® (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) for verification of polymorphisms (Altschul et al., 1997). 
Then, the selected target mycobacterial sequences available on GenBank (NCBI, http://www.
ncbi.nlm.nih.gov/) were aligned in BioEdit (Hall, 1999). After checking the ideal regions, 
namely those present only on M. bovis, the primers were designed in the program Primer3Plus 
(Untergasser et al., 2007), and analyzed using the program Oligo Analyser 3.1 (IDT, USA) 
for verification of secondary structures. In silico analytical specificity of the primers was 
tested with the PrimerBlast (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.
cgi?LINK_LOC=BlastHome) (Altschul et al., 1990).
The regions that were selected for the specific diagnosis of M. bovis were the gene 
coding for PE-PGRS 20 and the region of difference 4 (RD4). The primers used for PE-PGRS 
20 were Mbovis.100.F: 5'-GGC TGT GAT GCT GCT TCC-3' (205009-205026 position in the 
genome, BX248337.1) and Mbovis.100.R: 5'-CTC CGT GCT AGG ACG GTT-3' (position 
205108-205091), with a 100-bp segment being amplified. Primers for RD4 were Mbovis.88.F: 
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5'-CGC CTT CCT AAC CAG AAT TG-3' (78694-78713 position in the genome, BX248337.1) 
and Mbovis.88.R: 5'-GGA GAG CGC CGT TGT AGG-3' (78764-78781 position), with an 88-
bp segment being amplified.
The best concentration for both qPCRs (Mbovis.100 and Mbovis.88) was defined 
as 0.375 nM of each primer (IDT), 1.5 U Hot Start GoTaq Polymerase (Promega, USA), 
20% Colorless GoTaq Hot Start buffer 5X, 1.5 mM MgCl2, 1 µL 20X Eva Green (Biotium, 
Hayward, CA, USA), 2 μL Rox 10X (Biotium), 10 mM dNTP made up to a final volume of 
20 µL, and 2 μL DNA. The PCR stages contained a step at 95°C for 5 min, followed by 35 
cycles at 95°C for 15 s, 63°C for 20 s, and 72°C for 30 s, with the reading cycle length. The 
curve denaturation was performed at 72°C to 99°C, with intervals of fluorescence at every 1% 
rise in temperature.
Real-time PCRs (qPCR) were performed in ABI7500 (Applied Biosystems, USA). 
Tests were performed using trial and error adjustments, in accordance with primer concentra-
tions and annealing temperature, to adjust reagent concentrations. Samples were only consid-
ered positive when the curve analysis showed melting temperature peaks that did not differ by 
more than 1°C from the positive control used in the same experiment. All tests were performed 
with positive and negative controls and blank tubes to detect the reagent contamination.
Samples
Standard strains of M. bovis AN5 México CRNC 36, M. bovis AN5 CRNC 02, M. 
bovis AN5 CRNC 01, and M. bovis BCG CRNC were used as positive controls during all tests 
in this study. Standard strains of M. tuberculosis H37Rv CRNC 23 and M. tuberculosis H37Ra 
CRNC 25 were used as negative controls.
The following strains were used in analytical specificity tests: M. fortuitum CRNC 
10, M. kansasii CRNC 48, M. kansasii CRNC 18, M. gordonae CRNC 16, M. avium D4 
CRNC 05, M. avium paratuberculosis CRNC 26, M. avium 1500 CRNC 15, M. intracellulare 
CRNC 17, M. avium 2045 CRNC 14, M. marinum CRNC 19, M. scrofulaceum CRNC 49, M. 
scrofulaceum CRNC 20, M. szulgai CRNC 21, M. triviale CRNC 22, M. fortuitum peregrinum 
CRNC 11, M. phei CRNC 12, Rhodococcus equi CRC 09/01, Corynebacterium pseudotuber-
culosis CRC 09/02, and Nocardia asteroides CRC 10/01.
Four hundred and thirty (274 M. bovis and 156 M. tuberculosis) isolates from Brazil 
were used to test the diagnostic sensitivity and specificity. All of the samples that were tested 
were previously characterized biochemically. All M. tuberculosis samples were previously 
characterized by amplification of the pncA gene (Scorpio and Zhang, 1996), and its polymor-
phism was detected by the cleavage of the amplicon with Eco065I, as previously described 
(Barouni et al., 2004). This analysis was carried out at the Laboratory of Molecular Biology 
Applied to Mycobacteria, Oswaldo Cruz Institute, Fiocruz, Brazil.
Phenotype-based speciation methods 
All positive cultures were subjected to additional phenotypic speciation methods, in-
cluding biochemical tests to distinguish mycobacterial strains. Tests included catalase at room 
temperature and at 68°C. In addition niacin, nitrate, pyrazinamidase, urease, and drug suscep-
tibility testing were conducted (Kent and Kubica, 1985).
4611
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 13 (2): 4607-4616 (2014)
Validation of qPCR for the detection of Mycobacterium bovis
Validation criteria
The parameters for the validation methodology were performed using parameters de-
scribed in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals [OIE (World 
Organization for Animal Health), 2010] and as proposed by Fonseca Jr. et al. (2013).
Reaction efficiency 
 
The reaction efficiency was tested by diluting DNA samples extracted from M. bovis 
AN5 México CRNC 36 (Canevari Castelão et al., 2014). Each dilution was tested in dupli-
cate, and the concentration was estimated by the spectrophotometer UV light Nanovue® (GE 
Healthcare, Salt Lake City, UT, USA). Standard curves for both qPCRs were created to deter-
mine the optimal concentration of primers, which were defined as R2 minimum of 0.99 and a 
minimum efficiency of 90%.
Limit of detection (LOD)
LOD was determined by the dilution of the standard strain in base ten. The dilutions 
were tested in triplicate, and the LOD was determined as the dilution at which all replicates 
were positive. The LOD was confirmed by repeating the qPCR 21 times.
Repeatability and reproducibility
The repeatability was estimated using 7 samples of M. bovis. We extracted DNA from 
7 samples during 3 days of sampling, and submitted the extracted nucleic acid to qPCR in trip-
licate. To assess possible changes in the test, a second analyst performed the technique using 
the same criteria and the same samples.
Twenty-one samples were sent to another laboratory to assess interlaboratory repro-
ducibility. Sampling was performed according to OIE (World Organization for Animal Health, 
2010), using bacterial suspensions of M. bovis, M. tuberculosis, and mycobacteria other than 
M. tuberculosis.
Robustness
The following variables were analyzed as possible alternatives for the diagnosis of 
bovine TB. Four extraction kits were tested: Nucleospin Triprep® (Macherey Nagel, Beth-
lehem, PA, USA) DNeasy Blood & Tissue Kit® (Qiagen, Valencia, CA, USA), AccuPrep 
Genomic DNA Extraction Kit® (Bioneer, Alameda, CA, USA), and Genomic DNA Isolation 
Kit® (RBC, New Taipei City, Taiwan), in addition to boiling for 30 min at 90°C. The follow-
ing qPCR kits were also tested: Fast qPCR Master Mix Plus EvaGreen® (Biotium), 2.0X Re-
alQ-PCR Master Mix® with Sybr Green (Ampliqon, Odense, Denmark), and Platinum SYBR 
Green qPCR Supermix-UDG® (Invitrogen, Carlsbad, CA, USA). The 7 samples previously 
submitted to the qPCR technique were tested by all these kits in triplicate in the termocycler 
ABI7500 (Applied Biosystems). The qPCRs were also tested in the thermocycler Rotorgene 
3000 (Qiagen).
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Statistical analysis
We used the McNemar test to compare paired proportions, the kappa test to determine 
the measure of agreement between two tests classifying each sample, and the sensitivity and 
specificity analysis.
Sensitivity and specificity 
For the sensitivity and specificity analysis, 274 M. bovis and 156 M. tuberculosis iso-
lates from Brazil were used. Each sample was simultaneously tested by phenotypic and qPCR 
methods (Mbovis.100 and Mbovis.88). The qPCR method was compared with the phenotype-
based speciation method, as a gold standard.
RESULTS
qPCR
The efficiency of qPCR Mbovis.88 and qPCR Mbovis.100 was 100 and 90.96%, re-
spectively, with both having an R2 above 0.99. Melting peaks were 92.20°C for qPCR Mbo-
vis.100 (standard deviation 0.37°C) and 82.75°C for qPCR Mbovis.88 (standard deviation 
0.30°C).
LOD was calculated based on serial dilutions of M. bovis DNA. As indicated by the 
reaction efficiency, qPCR Mbovis.88 could detect lower quantities of bacterial DNA (4 pg) 
compared to qPCR Mbovis.100 (0.32 ng).
Repeatability, reproducibility, and robustness
The average values and standard deviations of Ct for each day in the repeatability and 
intralaboratory reproducibility tests for qPCR Mbovis.100 and qPCR Mbovis.88 are shown in 
Tables 1 and 2, respectively. The results indicate that both qPCRs may be reproduced in the 
laboratory without major differences in qualitative results. Reproducibility was 100% in the 
interlaboratory trials.
All qPCR kits and variations in DNA extraction produced similar results, with low 
standard deviations. The peaks in the melting curve analysis differed in each kit. Table 3 
shows variations in the denaturation temperature for qPCR Mbovis.100. Denaturation tem-
peratures were used for PCR kits “Fast-Plus EvaGreen qPCR Master Mix” (Biotium), and 
“2.0X RealQ-PCR with Sybr Green Master Mix” (Neobio, Brazil) and Rotor gene 3000 
(Qiagen).
Statistical analyses
The McNemar test showed no significant difference between both qPCR and the phe-
notypic tests. The Kappa test showed perfect agreement between the the two qPCRs and the 
phenotypic tests.
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Sensitivity and specificity
Neither qPCR amplified any reference sample from the genus Mycobacterium that was 
used in this study, besides M. bovis. Only one M. bovis isolate that was tested in the sensitivity 
test was not positive in qPCR Mbovis.100; however, all M. bovis isolates were positive in qPCR 
Mbovis.88. The DNA extracted from M. tuberculosis was not amplified in any qPCR. The diag-
nostic sensitivity and specificity for qPCR Mbovis.100 was 99.64% (95%CI = 97.98-99.94%) and 
100% (95%CI = 98.02-100%), respectively. The diagnostic sensitivity and specificity for qPCR 
Mbovis.88 was 100% (95%CI = 98.65-100%) and 100% (95%CI = 98.02-100%), respectively.
Sample                  Melting peak uncertainty
 1 2 3 4 5 6 7 8
Mean 91.87 92.12 91.93 92.46 89.48 93.43 91.45 95.55
σ   0.22   0.37   0.30   0.52   0.57   0.37   0.34    0.80
Maximum 92.09 92.49 92.30 92.48 90.06 93.81 91.79 96.36
Minimum 91.66 91.74 91.55 91.95 88.91 93.06 91.11 94.74
Table 3. Variation of melting curve peaks in robustness tests.
DNA extraction kits: 1 = AccuPrep Genomic DNA Extraction Kit (Bioneer); 2 = DNeasy Blood & Tissue Kit 
(Qiagen); 3 = Nucleospin Triprep; 4 = Genomic DNA Isolation Kit (Real Biotech Corporation). PCR kits: 5 = “Fast-
Plus EvaGreen qPCR Master Mix” (Biotium); 6 = “2.0X RealQ-PCR Master Mix com Sybr Green” (Neobio); 7 = 
Platinum SYBR Green qPCR Super Mix-UDG (Invitrogen); 8 = Equipament Rotor Gene 3000 (Qiagen).
Sample                 First analyst                     Second analyst
 Ct1 σ Ct2 σ Ct3 σ Ct1 σ Ct2 σ Ct3 Σ
1 22.41 0.28 18.94 0.03 16.08 0.12 17.92 0.05 22.15 0.17 18.13 0.60
2 21.13 0.01 20.48 0.08 17.55 0.07 20.34 0.10 23.66 0.12 18.80 0.95
3 21.37 0.08 24.31 0.09 21.89 0.10 20.05 0.07 24.15 0.12 22.63 0.07
4 23.98 0.26 24.73 0.07 18.49 0.11 24.57 0.22 24.40 0.07 26.86 0.12
5 20.19 0.08 22.47 0.11 20.26 0.16 20.54 0.07 27.02 0.74 25.18 0.05
6 22.92 0.04 20.57 0.03 19.84 0.28 21.18 0.20 23.79 0.46 22.56 1.36
7 25.89 0.12 21.86 0.04 21.05 0.05 23.24 0.11 26.74 0.14 20.41 0.09
PC 25.64 - 29.02 - 26.91 - 25.86 - 29.69 - 28.30
Table 1. Mean cycle threshold (Ct) values and standard deviation (σ) for each day of test (Ct1, Ct2, Ct3) for 
qPCR Mbovis.100 repeatability and reproducibility.
PC = positive control.
Sample                     First analyst                    Second analyst
 Ct1 σ Ct2 σ Ct3 σ Ct1 σ Ct2 σ Ct3 σ
1 21.44 0.24 18.52 0.15 17.45 0.14 19.30 0.43 19.58 0.29 18.48 0.11
2 20.78 1.10 16.28 0.09 15.15 0.87 17.91 0.07 16.67 0.45 16.86 0.13
3 24.37 0.15 21.85 0.23 20.25 0.13 25.22 0.32 25.45 0.80 24.42 0.61
4 22.96 0.23 20.45 0.38 19.23 0.23 21.77 0.22 22.20 0.27 21.13 0.20
5 25.89 0.28 23.19 0.49 21.35 0.33 27.26 0.35 27.50 0.11 25.81 0.08
6 27.98 0.54 24.94 0.09 22.26 0.22 31.60 0.32 31.87 0.57 29.10 0.12
7 23.62 0.07 20.64 0.14 19.06 0.24 22.19 0.31 22.64 0.34 21.49 0.31
PC 22.79 - 19.84 - 19.00 - 20.13  - 21.23 - 19.48 -
Table 2. Mean cycle threshold (Ct) values and standard deviation (σ) for each day of test (Ct1, Ct2, Ct3) for 
qPCR-88 repeatability and reproducibility.
PC = positive control.
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DISCUSSION
Both qPCR showed a high degree of diagnostic sensitivity and specificity compared to 
phenotypic analysis, demonstrating that the selected regions are useful for the differentiation 
of M. bovis and M. tuberculosis. The DNA sequence detected by qPCR Mbovis.88 (targeting 
RD4 in M. bovis genome) was only present in strains derived from M. bovis, and did not exist 
in the M. tuberculosis complex, even in those most genetically similar species like M. caprae 
(Garnier et al., 2003; Sales et al., 2014). Because of the MTC clonal profile and the low rate 
of recombination, a reversal in this deleted region is unlikely. The region detected by qPCR 
Mbovis.100 is a gene coding for 1 protein of the PE-PGRS family. Genetic variation occurs in 
the genes that code for PE-PGRS M. bovis and M. tuberculosis because of insertions and dele-
tions (Sreenu et al., 2006). These genetic factors, combined with the large sample size used 
in this study, increase the confidence in using these qPCRs for the identification of M. bovis.
The repeatability and reproducibility of a technique must be scientifically tested to en-
sure that the same diagnosis and identification of microorganisms is consistently obtained under 
different conditions. DNA extraction was responsible for differences in Ct values between days, 
analysts, and qPCR. Both qPCRs were developed for qualitative results; hence, the amount of 
DNA added to reaction mixes was not precise, varying between 20 and 200 ng, explaining the 
data shown in both tables. These two parameters must also be confirmed in the regulation for 
laboratory accreditation (Freitas et al., 2006). Hence, qPCR validation was essential to prove 
that the same results could be reproduced despite variations in day, analyst, reagents, equip-
ment, and laboratory.
Ring tests are part of the requirements for the validation of a diagnostic test [OIE (World 
Organization for Animal Health), 2010]; hence, the validation phases of a method should not 
only include tests within a laboratory, but proof of performance at different institutions as is 
known that PCR results may be slightly different in different laboratories, because of differences 
in equipment, reagents or the implementation procedures by different analysts (Eischeid, 2011). 
The interlaboratory tests conducted in this study produced 100% replicability. There were few 
variations in technique, because both laboratories use the same reagents and equipment for PCR; 
however, the results confirmed that both qPCRs could be performed safely in other laboratories.
To evaluate the performance of qPCR, we assessed different qPCR equipment, kit 
DNA extraction kits, and amplification kits. All resulting samples produced positive results, 
which were amplified with specific denaturation peaks when compared to the positive control.
The peaks in the melting curve analysis results were quite variable in all tests; how-
ever, these changes were expected. The Rotorgene 3000 has a different fluorescence detection 
and heat exchange system to ABI7500, which generates discrepant peaks in melting curves; 
however, this variation is minimal within the same equipment. Extraction kits generate differ-
ent residues during DNA extraction, including ions that influence DNA dissociation.
PCR mixes produced by different companies have buffers with factors causing differ-
ences at the specific point that the denaturation of the double-stranded DNA occurs (Wittwer 
et al., 2001). One of the kits used in this study had even had a different intercalating agent, 
SYBR Green, which has different saturation DNA molecule characteristics compared to Eva 
Green (Eischeid, 2011). Yet, the results remained consistent across all kits, confirming the 
robustness of the qPCRs. None of these factors invalidated the results or prevented the use of 
these reagents.
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The target regions for both of the qPCRs used in this study were based on long poly-
morphisms, which reduced the possibility of false-positive results. Besides the fact that a large 
number of samples were used to validate these techniques, long polymorphisms offer several 
advantages over other PCR techniques that rely only on single nucleotide polymorphisms 
(Goh et al., 2006), require electrophoresis on agarose gels (Shah et al., 2002), or use a small 
amount of samples  (Bakshi et al., 2005). The methodologies tested in this study proved to be 
reliable, despite the use of different reagents and equipment. These variables have not been 
subject to extensive testing in any of the previously published studies, despite representing 
common differences in molecular biology laboratories.
Both of the qPCRs analyzed in the present study have potential application as a rapid 
method for the diagnosis of bovine TB, and might also have public health utility, particularly 
in areas (or populations) where M. bovis is prevalent. Furthermore, these qPCRs could be used 
to obtain estimates of the prevalence or incidence rates of bovine and human infections caused 
by M. bovis. This strategy could be expanded beyond Brazil, for epidemiological purposes in 
areas such as Africa, Southeast Asia, Central America, South America, and other regions where 
M. bovis is transmitted from animals to humans (and vice-versa), or is a suspected problem.
ACKNOWLEDGMENTS
We thank CNPq (#410595/2006-3), INCT-Pecuária, and the Brazilian Ministry of 
Agriculture for providing financial support.
REFERENCES
Altschul SF, Gish W, Miller W, Myers EW, et al. (1990). Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
Altschul SF, Madden TL, Schaffer AA, Zhang J, et al. (1997). Gapped BLAST and PSI-BLAST: a new generation of 
protein database search programs. Nucleic Acids Res. 25: 3389-3402.
Bakshi CS, Shah DH, Verma R, Singh RK, et al. (2005). Rapid differentiation of Mycobacterium bovis and Mycobacterium 
tuberculosis based on a 12.7-kb fragment by a single tube multiplex-PCR. Vet. Microbiol. 109: 211-216.
Barouni AS, Augusto CJ, Lopes MT, Zanini MS, et al. (2004). A pncA polymorphism to differentiate between 
Mycobacterium bovis and Mycobacterium tuberculosis. Mol. Cell Probes 18: 167-170.
Canevari Castelão AB, Nishibe C, Moura A, de Alencar AP, et al. (2014). Draft genome sequence of Mycobacterium bovis 
strain AN5, used for production of purified protein derivative. Genome Announc. 2: e00277-14.
Eischeid AC (2011). SYTO dyes and EvaGreen outperform SYBR Green in real-time PCR. BMC Res. Notes 4: 263.
Fleischmann RD, Alland D, Eisen JA, Carpenter L, et al. (2002). Whole-genome comparison of Mycobacterium 
tuberculosis clinical and laboratory strains. J. Bacteriol. 184: 5479-5490.
Fonseca Jr AA, Cottorello AC, Dias NL, D’Ambros R, et al. (2013). PCR em tempo real para detecção do vírus da doença 
de Aujeszky. Arq. Bras. Med. Vet. Zootec. 65: 801-808.
Freitas EI, Lemos AA and Marin VA (2006). Validação de métodos alternativos qualitativos na detecção de patógenos 
alimentares. Ciênc. Saúde Coletiva 11: 1073-1083.
Garnier T, Eiglmeier K, Camus JC, Medina N, et al. (2003). The complete genome sequence of Mycobacterium bovis. 
Proc. Natl. Acad. Sci. U. S. A. 100: 7877-7882.
Goh KS, Fabre M, Huard RC, Schmid S, et al. (2006). Study of the gyrB gene polymorphism as a tool to differentiate among 
Mycobacterium tuberculosis complex subspecies further underlines the older evolutionary age of ‘Mycobacterium 
canettii’. Mol. Cell Probes 20: 182-190.
Hall TA (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/
NT. Nucleic Acids Symp. Ser. 41: 95-98.
Jou R, Huang WL and Su WJ (2009). Tokyo-172 BCG vaccination complications, Taiwan. Emerg. Infect. Dis. 15: 1525-
1526.
4616
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 13 (2): 4607-4616 (2014)
M.L. Sales et al.
Kent PT and Kubica GP (1985). Public Health Mycobacteriology: A Guide for the Level III Laboratory. Centers for 
Disease Control and Prevention, Atlanta.
Konno K, Feldmann FM and McDermott W (1967). Pyrazinamide susceptibility and amidase activity of tubercle bacilli. 
Am. Rev. Respir. Dis. 95: 461-469.
Martinez G, Harel J and Gottschalk M (2001). Specific detection by PCR of Streptococcus agalactiae in milk. Can. J. 
Vet. Res. 65: 68-72.
Ministério da Agricultura Pecuária e Abastecimento (2006). Programa Nacional de Controle e Erradicação da Brucelose e 
Tuberculose - PNCEBT. Ministério da Agricultura, Pecuária e Abastecimento, Brasília.
OIE (World Organization for Animal Health) (2010). Principles and Methods of Validation of Diagnostic Assays for 
Infectious Diseases. In: Terrestrial Manual. Paris Office International des Epizooties, Paris.
Reddington K, O’Grady J, Dorai-Raj S, Niemann S, et al. (2011). A novel multiplex real-time PCR for the identification 
of mycobacteria associated with zoonotic tuberculosis. PLoS One 6: e23481.
Sales ML, Fonseca AA Jr, Sales EB, Cottorello AC, et al. (2014). Evaluation of molecular markers for the diagnosis of 
Mycobacterium bovis. Folia Microbiol. Doi: 10.1007/s12223-014-0317-3. [Epub ahead of print].
Scorpio A and Zhang Y (1996). Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to 
the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2: 662-667.
Shah DH, Verma R, Bakshi CS and Singh RK (2002). A multiplex-PCR for the differentiation of Mycobacterium bovis 
and Mycobacterium tuberculosis. FEMS Microbiol. Lett. 214: 39-43.
Silva MR, Rocha AS, da Costa RR, de Alencar AP, et al. (2013). Tuberculosis patients co-infected with Mycobacterium 
bovis and Mycobacterium tuberculosis in an urban area of Brazil. Mem. Inst. Oswaldo Cruz, 108.
Somoskovi A, Dormandy J, Mayrer AR, Carter M, et al. (2009). “Mycobacterium canettii” isolated from a human 
immunodeficiency virus-positive patient: first case recognized in the United States. J. Clin. Microbiol. 47: 255-257.
Sreenu VB, Kumar P, Nagaraju J and Nagarajaram HA (2006). Microsatellite polymorphism across the M. tuberculosis 
and M. bovis genomes: implications on genome evolution and plasticity. BMC Genomics 7: 78.
Talbot EA, Williams DL and Frothingham R (1997). PCR identification of Mycobacterium bovis BCG. J. Clin. Microbiol. 
35: 566-569.
Untergasser A, Nijveen H, Rao X, Bisseling T, et al. (2007). Primer3Plus, an enhanced web interface to Primer3. Nucleic 
Acids Res. 35: W71-W74.
Wittwer CT, Herrmann MG, Gundry CN and Elenitoba-Johnson KS (2001). Real-time multiplex PCR assays. Methods 
25: 430-442.
